EAJAIC
Eurasian Journal of Anesthesiology and Intensive Care

The Eurasian Journal of Anesthesiology and Intensive Care (EAJAIC) is an independent-unbiased, peer-reviewed, "double-blind", and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, differential diagnoses, editorial opinions, letters to the editor, and educational papers in anesthesiology, algology, and intensive care medicine.

ISSN: Active
eISSN: 3023-6738
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Effects of dexmedetomidine on bupivacaine-induced myotoxicity and inflammation in rats
Abstract
Aims: The increasing use of regional anesthesia techniques has heightened concern regarding local anesthesia-related tissue damage. Bupivacaine is widely used because of its long duration of action and high potency, however it is associated with a high myotoxic potential. This study aims to evaluate whether the addition of dexmedetomidine as an adjuvant to bupivacaine during peripheral block may influence bupivacaine-induced myotoxicity and inflammation.
Methods: Twenty-eight Wistar albino rats were allocated into four equal groups. Group C received 0,2 mL of 0,9% normal saline, Group B received 0,2 mL of 0,25% bupivacaine, Group D received 0,2 mL of dexmedetomidine at a concentration of 0,005%, and Group BD received a combination of 0,25% bupivacaine and 0,005% dexmedetomidine. All injections were administered intramuscularly into the right gastrocnemius muscle. After 48 hours, muscle tissues were harvested for histopathological evaluation using the Modified Benoit Score. Serum creatine phosphokinase (CPK) and C-reactive protein (CRP) levels were measured.
Results: Group B demonstrated the highest histopathological damage scores. Scores in Group BD were lower than those in Group B but higher than those in Groups C and D. Serum CPK levels were significantly higher in Group B compared with the other groups. No statistically significant differences were observed among the groups with respect to CRP levels.
Conclusion: Dexmedetomidine was associated with a reduction in bupivacaine-induced myotoxicity in rats, as supported by histopathological and biochemical findings. These results suggest that dexmedetomidine may have the potential to reduce muscle injury when used as an adjuvant to local anesthetics, although further experimental and clinical studies are required.

Keywords : Bupivacaine, dexmedetomidine, myotoxicity

Download Article


1. Shams D, Sachse K, Statzer N, Gupta RK. Regional anesthesia complications and contraindications. Clin Sports Med. 2022;41(2):329-343. doi:10.1016/j.csm.2021.11.006
2. Brummett CM, Norat MA, Palmisano JM, Lydic R. Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat. Anesthesiology. 2008;109(3):502-511. doi: 10.1097/ALN.0b013e318182c26b
3. Zink W, Graf BM. Local anesthetic myotoxicity. Reg Anesth Pain Med. 2004;29(4):333-340. doi:10.1016/j.rapm.2004.04.002
4. Rwei AY, Sherburne RT, Zurakowski D, Wang B, Kohane DS. Prolonged duration local anesthesia using liposomal bupivacaine combined with liposomal dexamethasone and dexmedetomidine. Anesth Analg. 2018; 126(4):1170-1175. doi:10.1213/ANE.0000000000002771
5. Irwin W, Fontaine E, Agnolucci L, et al. Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem. 2002;277(14):12221-12227. doi: 10.1074/jbc.M111242200
6. Mao Q, Yu W, Liu S, et al. Downregulation of HSPA12A underlies myotoxicity of local anesthetic agent bupivacaine through inhibiting PGC1?-mediated mitochondrial integrity. Toxicol Appl Pharmacol. 2022;434:115798. doi:10.1016/j.taap.2021.115798
7. Plank C, Hofmann P, Gruber M, et al. Modification of bupivacaine-induced myotoxicity with dantrolene and caffeine in vitro. Anesth Analg. 2016;122(2):418-423. doi:10.1213/ANE.0000000000000988
8. Benoit PW, Yagiela JA, Ferrell Fort N, Fort JA. Pharmacologic correlation between local anesthetic-induced myotoxicity and disturbances of intracellular calcium distribution. Toxicol Appl Pharmacol. 1980;52(2):187-198. doi:10.1016/0041-008X(80)90105-2
9. Finneran JJ, Ilfeld BM. Peripheral nerve blocks. In: Butterworth JF, Mackey DC, Wasnick JD, eds. Morgan & Mikhail’s Clinical Anesthesiology. 7th ed. New York, NY: McGraw-Hill; 2022:975-1107.
10. Zink W, Seif C, Bohl JRE, et al. The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades. Anesth Analg. 2003;97(4):1173-1179. doi:10.1213/01.ANE.0000080610.14265.C8
11. Hussain N, McCartney CJL, Neal JM, Chippor J, Banfield L, Abdallah FW. Local anaesthetic-induced myotoxicity in regional anaesthesia: a systematic review and empirical analysis. Br J Anaesth. 2018;121(4):822-841. doi:10.1016/j.bja.2018.06.013
12. Shoshan-Barmatz V, Zchut S. The interaction of local anesthetics with the ryanodine receptor of the sarcoplasmic reticulum. J Membr Biol. 1993;133(2):171-181. doi:10.1007/BF00233049
13. Zink W, Graf BM, Sinner B, Martin E, Fink RHA, Kunst G. Differential effects of bupivacaine on intracellular Ca² regulation: potential mechanisms of its myotoxicity. Anesthesiology. 2002;97(3):710-716. doi: 10.1097/00000542-200209000-00027
14. Nouette-Gaulain K, Bellance N, Pré B, et al. Erythropoietin protects against local anesthetic myotoxicity during continuous regional analgesia. Anesthesiology. 2009;110(4):821-831. doi:10.1097/ALN.0b013e 31819c4a4f
15. Nouette-Gaulain K, Bringuier S, Canal-Raffin M, et al. Time course of mitochondrial metabolism alterations to repeated injections of bupivacaine in rat muscle. Can J Anaesth. 2010;57(9):836-842. doi:10. 1007/s12630-010-9337-2
16. Öz Gergin Ö, Yildiz K, Bayram A, et al. Comparison of the myotoxic effects of levobupivacaine, bupivacaine, and ropivacaine: an electron microscopic study. Ultrastruct Pathol. 2015;39(3):169-176. doi:10.3109/01913123.2015.1028429
17. Horiguchi T, Shibata MA, Ito Y, Eid NAS, Abe M, Otsuki Y. Macrophage apoptosis in rat skeletal muscle treated with bupivacaine hydrochloride: possible role of MCP-1. Muscle Nerve. 2002;26(1):79-86. doi:10.1002/mus.10166
18. Yildiz K, Efesoy SN, Ozdamar S, et al. Myotoxic effects of levobupivacaine, bupivacaine and ropivacaine in a rat model. Clin Invest Med. 2011;34(5):E273-E281. doi:10.25011/cim.v34i5.15365
19. Foster AH, Carlson BM. Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Muscle Nerve. 1980;3(4):286-293. doi:10.1002/mus.880030405
20. Zhang C, Phamonvaechavan P, Rajan A, Poon DY, Topcu-Yilmaz P, Guyton DL. Concentration-dependent bupivacaine myotoxicity in rabbit extraocular muscle. J AAPOS. 2010;14(4):323-327. doi:10.1016/j.jaapos.2010.05.004
21. Benoit PW. Reversible skeletal muscle damage after administration of local anesthetics with and without epinephrine. J Oral Surg. 1978;36(3): 198-201. doi:10.1016/S0030-4220(78)80005-1
22. Guttu RL, Page DG, Laskin DM. Delayed healing of muscle after injection of bupivacaine and steroid. Ann Dent. 1990;49(1):5-8.
23. Padera RF, Tse JY, Bellas E, Kohane DS. Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity. Muscle Nerve. 2006;34(6): 747-753. doi:10.1002/mus.20633
24. Culebras X, Van Gessel E, Hoffmeyer P, Gamulin Z. Clonidine combined with a long acting local anesthetic does not prolong postoperative analgesia after brachial plexus block but does induce hemodynamic changes. Anesth Analg. 2001;92(1):199-204. doi:10.1097/00000539-200101000-00039
25. Duma A, Urbanek B, Sitzwohl C, Kreiger A, Zimpfer M, Kapral S. Clonidine as an adjuvant to local anaesthetic axillary brachial plexus block: a randomized, controlled study. Br J Anaesth. 2005;94(1):112-116. doi:10.1093/bja/aei012
26. Kanazi GE, Aouad MT, Jabbour-Khoury SI, et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006;50(2):222-227. doi:10.1111/j. 1399-6576.2006.00919.x
27. Erdivanli B, Altun M, Sezen ÖK, Çolakoğlu SA. Anti-nociceptive, analgesic and pathohistological effects of intrathecal dexmedetomidine and bupivacaine in rats. Rev Bras Anestesiol. 2013;63(4):373-379. doi:10. 1016/j.bjane.2012.08.004
28. Aksu R, Patmano G, Biçer C, Emek E, Çoruh AE. Efficiency of bupivacaine and association with dexmedetomidine in transversus abdominis plane block ultrasound guided in postoperative pain of abdominal surgery. Braz J Anesthesiol (Engl Ed). 2018;68(1):49-56. doi: 10.1016/j.bjane.2017.09.004
29. Campoy L, Martin-Flores M, Boesch JM, et al. Transverse abdominis plane injection of bupivacaine with dexmedetomidine or a bupivacaine liposomal suspension yielded lower pain scores and requirement for rescue analgesia in a controlled, randomized trial in dogs undergoing elective ovariohysterectomy. Am J Vet Res. 2022;83(9):729-738. doi:10. 2460/ajvr.22.03.0045
30. Manzoor S, Taneja R, Sood N, Puri A, Kadayaprath G. Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries. J Anaesthesiol Clin Pharmacol. 2018;34(2): 227-231. doi:10.4103/joacp.JOACP_310_16
31. Jin Z, Xia F, Lin T, Cai Y, Chen H, Wang Y. Dexmedetomidine may decrease the bupivacaine toxicity to heart. Open Med (Poland). 2021; 16(1):1070-1075. doi:10.1515/med-2021-0300
32. Miller DL, Dou C, Dong Z, Raghavendran K. The influence of dexmedetomidine on ultrasound-induced pulmonary capillary hemorrhage in rats. Ultrasound Med Biol. 2016;42(4):964-970. doi:10. 1016/j.ultrasmedbio.2015.12.004
33. Sun Y, Liu C, Zhang Y, et al. Low-dose intramuscular dexmedetomidine as premedication: a randomized controlled trial. Med Sci Monit. 2014; 20:2714-2719. doi:10.12659/MSM.891099
34. Nosaka K, Sakamoto K. Changes in plasma enzyme activity after intramuscular injection of bupivacaine into the human biceps brachii. Acta Physiol Scand. 1999;167(3):259-265. doi:10.1046/j.1365-201X.1999. 00502.x
35. He Y, Yang Z, Li J, Li E. Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells. Exp Mol Pathol. 2020;113:104380. doi:10.1016/j.yexmp.2020.104380
36. Wong MB, Wong DH. Regional anaesthesia for intraocular surgery. Can J Anaesth. 1993;40(7):635-642. doi:10.1007/BF03009716
37. Gómez-Arnau JI, Yangüela J, González A, et al. Anaesthesia-related diplopia after cataract surgery. Br J Anaesth. 2003;90(2):189-193. doi:10. 1093/bja/aeg046
38. Parris WC, Dettbarn WD. Muscle atrophy following nerve block therapy. Anesthesiology. 1988;69(2):289-294. doi:10.1097/00000542-198808000-00021
Article available in :
Volume 3, Issue 1, 2026
Page : 8-15
https://doi.org/10.51271/EAJAIC-0046
Article Information
Received : 01 Oca 2026
Accepted : 29 Oca 2026
Published : 09 Şub 2026
Corresponding Author :

Gülay Yalçın Yılmaz: Department of Anesthesiology and Reanimation, Ankara Bilkent City Hospital, Ankara, Turkiye

[email protected]
Citation : Yalçın Yılmaz G, Akçaboy EY, Diker MS, Akçaboy ZN, Yılmaz MC, Karagece Yalçın Ü. Effects of dexmedetomidine on bupivacaine induced myotoxicity and inflammation in rats. Eur J Anesthesiol Intens Care. 2026;3(1):8-15.

Read: 174
Download : 132
Cited: 0
_Footer